Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis

被引:31
作者
Dong, Charlotte X. [1 ]
Brubaker, Patricia L. [1 ]
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
基金
加拿大健康研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; REDUCES FOOD-INTAKE; PROTEIN-COUPLED RECEPTORS; GASTRIC BYPASS; BODY-WEIGHT; INSULIN-SECRETION; CELL-FUNCTION; GUT HORMONE; FATTY-ACIDS; IN-VIVO;
D O I
10.1038/nrgastro.2012.185
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dysregulation of nutrient homeostasis is implicated in the current epidemics of obesity and type 2 diabetes mellitus. The maintenance of homeostasis in the setting of repeated cycles of feeding and fasting occurs through complex interactions between metabolic, hormonal and neural factors. Although pancreatic islets, the liver, muscle, adipocytes and the central nervous system are all key players in this network, the gastrointestinal tract is the first tissue exposed to ingested nutrients and thus has an important role. This Review focuses on several of the endocrine hormones released by the gastrointestinal tract prior to or during nutrient ingestion that have key roles in maintaining energy balance. These hormones include the gastric orexigenic hormone, ghrelin, and the distal L cell anorexigenic and metabolic hormones, glucagon-like peptide (GLP)-1, GLP-2, oxyntomodulin and peptide YY. Each of these hormones exerts a distinct set of biological actions to maintain nutrient homeostasis, the properties of which are currently, or might soon be, exploited in the clinic for the treatment of obesity and type 2 diabetes mellitus. Dong, C. X. & Brubaker, P. L. Nat. Rev. Gastroenterol. Hepatol. 9, 705-715 (2012); published online 2 October 2012; doi:10.1038/nrgastro.2012.185
引用
收藏
页码:705 / 715
页数:11
相关论文
共 190 条
  • [31] Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis
    Boushey, RP
    Yusta, B
    Drucker, DJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (05): : E937 - E947
  • [32] Boushey RP, 2001, CANCER RES, V61, P687
  • [33] Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
    Brubaker, Patricia L.
    [J]. ENDOCRINOLOGY, 2010, 151 (05) : 1984 - 1989
  • [34] Teduglutide, a Novel Mucosally Active Analog of Glucagon-Like Peptide-2 (GLP-2) for the Treatment of Moderate to Severe Crohn's Disease
    Buchman, Alan L.
    Katz, Seymour
    Fang, John C.
    Bernstein, Charles N.
    Abou-Assi, Souheil G.
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (06) : 962 - 973
  • [35] Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat
    Bucinskaite, V.
    Tolessa, T.
    Pedersen, J.
    Rydqvist, B.
    Zerihun, L.
    Holst, J. J.
    Hellstrom, P. M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (09) : 978 - e78
  • [36] Cholecystokinin Regulates Expression of Y2 Receptors in Vagal Afferent Neurons Serving the Stomach
    Burdyga, Galina
    de Lartigue, Guillaume
    Raybould, Helen E.
    Morris, Richard
    Dimaline, Rod
    Varro, Andrea
    Thompson, David G.
    Dockray, Graham J.
    [J]. JOURNAL OF NEUROSCIENCE, 2008, 28 (45) : 11583 - 11592
  • [37] Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO
  • [38] 2-E
  • [39] DIVERGENT TISSUE-SPECIFIC AND DEVELOPMENTAL EXPRESSION OF RECEPTORS FOR GLUCAGON AND GLUCAGON-LIKE PEPTIDE-1 IN THE MOUSE
    CAMPOS, RV
    LEE, YC
    DRUCKER, DJ
    [J]. ENDOCRINOLOGY, 1994, 134 (05) : 2156 - 2164
  • [40] Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats
    Chambers, Adam P.
    Jessen, Lene
    Ryan, Karen K.
    Sisley, Stephanie
    Wilson-Perez, Hilary E.
    Stefater, Margaret A.
    Gaitonde, Shrawan G.
    Sorrell, Joyce E.
    Toure, Mouhamadoul
    Berger, Jose
    D'Alessio, David A.
    Woods, Stephen C.
    Seeley, Randy J.
    Sandoval, Darleen A.
    [J]. GASTROENTEROLOGY, 2011, 141 (03) : 950 - 958